(Total Views: 531)
Posted On: 11/21/2023 2:15:07 PM
Post# of 154721
If you didn't think the hold was BS, this from Dr. Lalezari's email:
The CD10 study continued to demonstrate the safety of leronlimab. Altogether, over 1,200 patients have now received the drug, including HIV+, Cancer, and Covid patients, without a discernible safety signal.
The CD10 study continued to demonstrate the safety of leronlimab. Altogether, over 1,200 patients have now received the drug, including HIV+, Cancer, and Covid patients, without a discernible safety signal.
(12)
(0)
